Pfizer

Updated ET, Sat ,

Pfizer said Tuesday it signed a licensing agreement to allow broader global access to its experimental Covid-19 pill. ...
Testing found Pfizer’s pill to be 89% effective at reducing the risk of hospitalization and death from Covid-19 when taken soon after diagnosis. ...
Pfizer Inc. has signed a deal with a U.N.-backed group to allow other manufacturers to make its experimental Covid-19 pill, a move that could make the treatment available to more than half of the world’s population. Earlier this month, Pfizer said the pill cut the risk of hospitalization and death by nearly 90 percent in people with mild to moderate infections. Dr. Nahid Bhadelia joins José Díaz-Balart to discuss.  ...
Pfizer on Tuesday announced an agreement allowing other companies to make its potential coronavirus antiviral pill in poorer countries. ...

( )